# DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

> **NCT00077077** · PHASE1 · COMPLETED · sponsor: **Daiichi Sankyo**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** DJ-927
- **DRUG:** capecitabine

## Key facts

- **NCT ID:** NCT00077077
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** — (—)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00077077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00077077, "DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00077077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*